Familial melanoma
ORPHA:618DiseaseAutosomal dominant, Multigenic/multifactorialAdult
Ассоциированные гены11
| Ген | Полное название | Тип связи | Тип гена | OMIM |
|---|---|---|---|---|
| CDK4 | cyclin dependent kinase 4 | Major susceptibility factor in | gene with protein product | 123829 |
| CDKN2A | cyclin dependent kinase inhibitor 2A | Major susceptibility factor in | gene with protein product | 600160 |
| MITF | melanocyte inducing transcription factor | Major susceptibility factor in | gene with protein product | 156845 |
| TERT | telomerase reverse transcriptase | Major susceptibility factor in | gene with protein product | 187270 |
| MC1R | melanocortin 1 receptor | Major susceptibility factor in | gene with protein product | 155555 |
| BAP1 | BRCA1 associated deubiquitinase 1 | Major susceptibility factor in | gene with protein product | 603089 |
| CDKN2B | cyclin dependent kinase inhibitor 2B | Candidate gene tested in | gene with protein product | 600431 |
| MGMT | O-6-methylguanine-DNA methyltransferase | Major susceptibility factor in | gene with protein product | 156569 |
| POT1 | protection of telomeres 1 | Major susceptibility factor in | gene with protein product | 606478 |
| ACD | ACD shelterin complex subunit and telomerase recruitment factor | Major susceptibility factor in | gene with protein product | 609377 |
| TERF2IP | TERF2 interacting protein | Major susceptibility factor in | gene with protein product | 605061 |
Фенотипы (HPO)11
Очень частый (80–99%)2
HP:0002861Melanoma
HP:0003764Nevus
Частый (30–79%)4
HP:0000958Dry skin
HP:0001480Freckling
HP:0001595Abnormality of the hair
HP:0100763Abnormality of the lymphatic system
Периодический (5–29%)5
HP:0000488Retinopathy
HP:0002071Abnormality of extrapyramidal motor function
HP:0002894Neoplasm of the pancreas
HP:0006753Neoplasm of the stomach
HP:0100013Neoplasm of the breast
Эпидемиология2
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | 1-9 / 100 000 | 1.5 | Europe | Value and class |
| Point prevalence | Unknown | — | Worldwide | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)